RVTY — Revvity Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual income statement for Revvity, fiscal year end - January 1st, USD millions except per share, conversion factor applied.

	2019 December 29th	2021 January 3rd	R2022 January 2nd	2023 December 31st	2023 January 1st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,884	3,783	3,828	2,751	3,312
Cost of Revenue
Gross Profit	1,396	2,110	2,434	1,540	1,990
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,557	2,804	2,569	2,450	2,569
Operating Profit	327	979	1,258	301	743
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	237	906	1,204	183	652
Provision for Income Taxes
Net Income After Taxes	230	728	889	180	513
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	228	728	943	693	569
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	228	728	943	693	569
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.7	6.75	8.14	2.23	4.31
Dividends per Share